UK Hospital expected to get shipment of new COVID-19 booster next week
A new booster against COVID-19 has been approved by the U.S. Food and Drug Administration. It was also signed off on by the Center for Disease Control and Prevention. This booster is designed to help fight the original strain of COVID-19 as well as current subvariants.
Jim Hallahan is the assistant director of pharmacy operations at University of Kentucky Healthcare. He says the process is a little different depending on which version someone gets.
“For the Moderna variant, it is eligible for individuals 18 years old or older. They’re eligible for this single booster dose as long as they have been at least two months since receiving primary vaccination which is considered your first two doses.”
Hallahan says it is similar with the Pfizer booster. Only that booster can be given to anyone twelve and older that is two months out from their previous COVID vaccine.
Vince Venditto is an associate professor in the UK College of Pharmacy. He said it is important for everyone to remain vigilant and not let their guard down when it comes to COVID-19.
“There’s a lot of evidence now coming out, showing that even mild cases of COVID lead to long term complications. Increased complications of cardiovascular risk and other things that we never anticipated when this first started circulating.”
UK hospital is expected to receive their first doses of the new booster early next week.
**In a sea of partisan news, WEKU is your source for public service, fact-based journalism. Monthly sustaining donors are the top source of funding for this growing nonprofit news organization. Please join others in your community who support WEKU by making your donation.